User login
A Comprehensive Investigation of Barriers to Adult Immunization A Methods Paper
OBJECTIVES: Immunization rates for influenza and pneumococcal vaccines among the elderly (especially minority elderly) are below desired levels. We sought to answer the following 4 questions: (1) What factors explain most missed immunizations? (2) How are patient beliefs and practices regarding adult immunization affected by racial or cultural factors? (3) How are immunizations and patient beliefs affected by physician, organizational, and operational factors? and (4) Based on the relationships identified, can typologies be created that foster the tailoring of interventions to improve immunization rates?
STUDY DESIGN: A multidisciplinary team chose the PRECEDE-PROCEED framework, the Awareness to Adherence model of clinician response to guidelines, and the Triandis model of consumer decision making as the best models to assess barriers to and facilitators of immunization. Our data collection methods included focus groups, face-to-face and telephone interviews, self-administered surveys, site visits, participant observation, and medical record review.
POPULATION: To encounter a broad spectrum of patients, facilities, systems, and interventions, we sampled from 4 strata: (1) inner-city neighborhood health centers, (2) clinics in Veterans Administration facilities, (3) rural practices in a network, and (4) urban/suburban practices in a network. In stage 1, a stratified random cluster sample of 60 primary care clinicians was selected, 15 in each of the strata. In stage 2, a random sample of 15 patients was selected from each clinician’s list of patients, aiming for 900 total interviews.
CONCLUSION: This multicomponent approach is well suited to identifying barriers to and facilitators of adult immunizations among a variety of populations, including the disadvantaged.
- An increase in adult immunization rates requires individualized interventions that account for the organization and culture of each family medicine practice.
- Assessment of the characteristics of a practice depends on a thorough investigation of provider and patient knowledge, attitudes, beliefs and practices regarding immunization.
- The PRECEDE-PROCEED framework using the Awareness to Adherence and Triandis models creates useful theoretical models for evaluating the characteristics of family medicine practices.
- Typologies developed from this procedure may help to simplify the process of characterizing practices and developing individualized immunization interventions.
Together, influenza and pneumonia are the sixth leading cause of death. Each year, influenza causes approximately 20,000 deaths, and pneumococcus causes approximately 500,000 cases of pneumonia, 50,000 cases of bacteremia, and 3000 cases of meningitis.1,2 African Americans experience approximately twice the rate of invasive pneumococcal disease as whites.3,4
Despite the burden of disease and the availability of vaccine guidelines,1,2,5-7 vaccination rates are only modest, though they are slowly rising. In 1997, only 65% and 45% of persons 65 years or older reported receiving influenza and pneumococcal vaccines, respectively.8 Influenza vaccination rates were lower for persons of Hispanic (58%) and non-Hispanic black (50%) origin than for non-Hispanic whites (67%). Pneumococcal vaccination rates were 34% for Hispanics, 30% for non-Hispanic blacks, and 47% for non-Hispanic whites.8
The low rates are surprising, given that there is an abundance of literature reporting successful interventions for increasing immunization rates.9,10 In a meta-analysis, system-oriented interventions (eg, standing orders for nurses) resulted in pooled rate increases of 39% and 45% for influenza and pneumococcal vaccines, respectively.9 Patient-oriented strategies (eg, postcard reminders that influenza or pneumococcal vaccine was due) resulted in increases of 12% and 75%, respectively. Provider-oriented strategies (eg, chart reminders) resulted in increases of 18% and 8%, respectively, for influenza and pneumococcal vaccines.9
Causes of low immunization rates
Although immunization rates are slowly increasing, why have they not risen more, given the evidence of effective interventions? We believe that there are 4 primary reasons why many clinical practices have not successfully applied research findings to improve adult vaccination rates.
First, offices are complex systems with idiosyncratic organization structures and values. They tend to accept changes when they are congruent with the organization’s goals and culture. Most previous efforts at intervention treated practices uniformly, with a “one size fits all” approach.2,11 However, data from the Direct Observation of Primary Care Study reveals a wide variety of patients and problems.12-14 Several authors have recommended tailoring interventions to match the organizational structure, office culture, and individual physician philosophies and practices as a means of increasing the likelihood of success.11,12,15,16
Also, patient beliefs about adult vaccination are varied and include racial and ethnic diversity as well. Significant percentages of the elderly report lack of awareness of the need for immunizations (19% for influenza vaccination and 57% for pneumococcal vaccination).17-19 Among racial groups, non-Hispanic blacks were least aware of the need for these vaccines, followed by Hispanics and non-Hispanic whites.17 Concern that vaccination may actually cause disease17,20 and fear of the pain of injection and/or needles17,21,22 lead many to decline vaccination. Although serious adverse events due to vaccination are rare, media attention to them increases public awareness of their occurrence and may contribute to fear of adverse reactions.17,20-23
Time pressures on physicians also distract attention from prevention. Zyzanski and colleagues24 found that physicians seeing high volumes of patients, in comparison to those with low volumes, had visits that were 30% shorter, scheduled fewer patients for well-care visits, delivered fewer preventive screenings, and gave fewer immunizations.
Finally, the responsibility for adult immunization has not been definitively assigned, resulting in fewer programmatic efforts. Many groups have an interest in adult immunization; however, coordination is limited, causing immunization messages to become diffuse. As a result, many providers caring for adults do not see vaccination as their responsibility.
The cumulative effect of these factors is that, despite access to medical care, many of the adults at high risk for vaccine-preventable diseases remain unvaccinated.25
Research Questions
- Several research questions emerge from this scenario:
- What are the influenza and pneumococcal vaccination rates among persons 65 years and older of both majority and minority populations?
- What are the internal structure and office culture of various medical practices, and how do they facilitate or inhibit adult immunizations?
- What are providers’ attitudes, knowledge, and practices regarding adult immunizations?
- What are patients’ attitudes, knowledge, and beliefs regarding influenza and pneumococcal immunizations?
- What are the relationships among patient and provider knowledge, attitudes, beliefs, and practices and their impact on adult influenza and pneumococcal immunization rates?
- To answer these questions, a large multicomponent study with a variety of physician practice types and patient populations is required. Also, both quantitative and qualitative data need to be collected. In this article, we will describe the development of the methods used to answer these research questions.
Methods
Theoretical Framework and Models
To design our questionnaires, we used data from the literature, observations of the investigators, and 2 theoretical models: the Awareness to Adherence physician decision-making model and the Triandis consumer decision-making model.
The Awareness to Adherence model was developed to understand how physicians comply with new national practice guidelines for hepatitis B.26 It was chosen because it is perhaps the only theoretical model that has both been designed and tested to explain the vaccination behavior of clinicians. This model includes 4 sequential cognitive and behavioral steps: awareness, agreement, adoption, and adherence. It is similar to the Stages of Change model of precontemplation, contemplation, preparation, action, and maintenance.27 Shortly after national recommendations for hepatitis B vaccination of all infants, 98% of physicians were aware of them; 70% agreed with them; 55% adopted them; and 30% adhered to them.26 Interventions to improve compliance with any given recommendation can fail if the specific problem of either awareness, agreement, adoption, or adherence is not identified and addressed. For example, efforts at further dissemination are the most common type of intervention to increase compliance, but in the case of hepatitis B vaccinations for children, 98% of physicians were aware of the guidelines. Therefore, further attempts to increase physicians’ awareness would be unlikely to increase vaccination rates.
The Triandis model has been used to understand consumer decision making and is based on the theory of reasoned action. We chose it for several reasons. First, The Triandis model as used for influenza immunization is internally consistent (Chronbach a = .91) and has been externally validated.28 Second, it is broader than earlier models in that it accounts not only for beliefs, but also for values, social networks, habits, and physician influence on patients. Third, the Triandis model is able to predict behavior in a variety of cultural and economic situations.28-31
Although these 2 models capture behavioral and educational issues related to health practices, they miss systemwide interventions such as standing orders that have had a major impact in raising immunization rates. Thus, we sought a larger framework that was comprehensive, would allow us to incorporate behaviorally oriented models as well as system interventions, and would facilitate the development of interventions. We chose the PRECEDE-PROCEED framework, a systematic process to evaluate health problems and design intervention programs.32 PRECEDE, an acronym for the Predisposing, Reinforcing, and Enabling Constructs in Educational Diagnosis and Evaluation, is an educational diagnosis model developed in the 1970s. PROCEED, an acronym for Policy, Regulatory, and Organizational Constructs in Educational and Environmental Development, was added to the model in 1991.32 PRECEDE-PROCEED offers specific guidelines for analysis of target populations so that the appropriateness of specific interventions can be determined.32 Although not a theory itself, PRECEDE-PROCEED provides a framework for applying theories. A key element of this framework is participation by the population in defining its problems and goals (Phase 1). In Phase 2, an epidemiologic diagnosis sets priorities for the community’s health problems so that resources can be applied to interventions that will have the most impact. Phase 3 is the behavioral and environmental diagnosis that helps planners determine risk factors for a particular problem and which of those risk factors are amenable to change. Phase 4, the educational and organizational diagnosis, enables planners to determine the predisposing, reinforcing, and enabling factors that influence the likelihood that behavioral and environmental change will occur. Those factors within an organization that have the capacity to facilitate or hinder the implementation of a program are determined in Phase 5 Figure 1. Phase 6 is the implementation phase, and Phases 7 to 9 comprise the evaluations of the process, impact, and outcome of the intervention program.
Triangulation
We also employed triangulation, a process that assesses the problem from multiple vantage points using multiple data collection techniques and multiple data sources Table 1.33 The vantage points from which we collected data were the patient, the health care provider, and the health care organization. Our data collection techniques included focus groups, face-to-face and telephone interviews, self-administered surveys, site visits, participant observation, and medical record review. These methods provided data that are both quantitative (eg, immunization histories, demographics, surveys) and qualitative (eg, participant observations and focus group findings). Table 2 shows the relationships of the theoretical models and the specific research questions.
Conducting a study that collects both quantitative and qualitative methods requires the expertise of a multidisciplinary team. Our team included members from the disciplines of family medicine, preventive medicine, public health, internal medicine, medical sociology, medical anthropology, geriatrics, epidemiology, survey research, and biostatistics. This diversity in research backgrounds further broadens the perspective of the project.
Nested Sampling Design
The barriers to and facilitators of immunizations likely vary by characteristics of the patient population, by the mission of the health care facility, by the beliefs of the physicians, and by its internal operations and policies. We selected 4 types of facilities as our 4 strata to ensure access to a broad spectrum of patients, facilities, and policies, including: (1) inner-city neighborhood health centers serving economically disadvantaged populations with a high proportion of African American patients, (2) clinics in a Veterans Administration facility that also provides care for the underserved and which has an institutionwide program for increasing influenza and pneumococcal vaccination rates, (3) rural practices in a network, and (4) urban/suburban practices in a network.
A 2-stage stratified random cluster sampling was conducted to select participants. In stage 1, a stratified random cluster sample of 60 primary care clinicians (physicians, physician assistants, or nurse practitioners) was selected, 15 in each of the 4 strata. In stage 2, a randomly selected list of patients 66 years and older and seen in the office on or after October 1, 1998, was developed for each clinician. A random sample of 22 patients was then selected from each of these lists, with a target of 15 completed patient interviews per clinician. A total of 900 (60*15) patient interviews was the goal. This design allowed us to assess relationships among patient beliefs and behaviors, clinician beliefs and behaviors, and office systems and immunization records.
IRB Approval
This study was reviewed and approved by the Institutional Review Board of the University of Pittsburgh and the Human Use Subcommittee of the Institutional Review Board of the Veterans Affairs Healthcare System of Pittsburgh.
Data Collection
Seven survey instruments were used, 4 (1 each for physicians, nurses, office managers, and those patients followed by the anthropologists) were self-administered questionnaires of 19 to 59 items, primarily using scales and other quantitative measures. Three (1 each for physicians, nurses, and patients) were questionnaires used in face-to-face or telephone interviews that included open-ended questions.
All instruments were developed in a lengthy process of internal review and revision. The final drafts were piloted locally—the provider instruments on practicing primary care physicians, nurse practitioners, and nurses, and the patient instrument on visitors to a local senior citizen center. Subsequently, revisions were made.
Between July 1999 and December 1999, members of the research team visited each of the participating practices to further explain the project, photograph the office physical environment, collect floor plans, collect patient immunization related materials, distribute self-administered questionnaires, and complete as many face-to-face interviews as feasible.
On completion of the provider surveys and office visits, the patient telephone survey was initiated. To encourage patient participation, an endorsement letter from the clinician on practice stationery was mailed to patients, and they were offered a $20 honorarium. The patient questionnaire was programmed for computer-assisted telephone interviewing (CATI). CATI permits direct data entry during the interview, manages the sample of persons to be contacted, directs the sequence of questions, eliminates unintentionally skipped questions, and provides automatic range and logic checks.34 Subsequently, medical records were reviewed using a standard form to collect information on immunization and other preventive services and to verify patient reported immunization status.
Participant/Practice Observation
On a subsample of the large study, we pursued a participant/practice observation study, in which 8 of the 24 practices were recruited, 2 from each of the 4 strata. Within the strata, an attempt was made to select 2 diverse practices, based on the number of clinicians, clinician sex, and clinician-to-patient ratio. An additional site was selected for pilot testing of the methodology.
Selected practices were divided between 2 trained anthropologists who spent 2 full workdays at each of their assigned sites. Following a prescribed protocol, their task was to observe the office practice, the interpersonal styles of the clinicians, and the office environment and culture. They also observed provider-patient interactions for 3 to 5 patients per practice and interviewed the patients following their examinations to assess their overall satisfaction and experience with the clinic. Also, the team reviewed information obtained from the face-to-face interviews of clinicians and nurses.
A systematic process of review of all observations occurred throughout the data collection to insure the trustworthiness of these data based on techniques used by Silverman and coworkers.35 The first level of review was to discuss all observations among the 3 anthropologists following the collection of observation data of each site. This served to identify gaps in the data collection or areas where observations required some confirmation for accuracy and interpretation. The second level of review was through discussions at the weekly research team meetings for data verification and clarification of interpretation. Finally, the 8 sites were classified into types based on similarities in organizational structure, operational characteristics, and physician and staff philosophy.
Focus Groups
Two focus groups were held with senior adults who were not among the patients participating in the study. One group consisted of 14 African Americans, and the other consisted of 10 whites; both sexes were represented. Participants were recruited through a local senior center, where the focus groups were conducted. Discussion addressed issues of barriers to and facilitators of immunization and recommendations for improving immunization rates.
Statistical Methods
Qualitative data analysis methods such as the creation of code books was used to categorize the provider and staff responses to the interviewer questions and participant observations. These categorized responses were then used in the quantitative analysis in both bivariate and logistic regression models.36
The quantitative analysis of the data must take into account the cluster-correlated nature of the data which results from a complex multistage stratified clustered sampling strategy. For this reason, we used statistical software that can compute standard errors, regression coefficients, and other statistics in accordance with the sample design.37 Frequencies of patient responses to questions were computed using both quantitative and coded qualitative items. Bivariate relationships were examined, followed by logistic regression modeling, with receipt versus nonreceipt of vaccines as the dependent variable. Models were developed for each of the influenza and pneumococcal vaccines as dependent variables.
Discussion
Relevance of This Methodology for Future Interventions
The application of the PRECEDE-PROCEED framework and Awareness to Adherence and Triandis models to the study of provider and patient attitudes, knowledge, beliefs, and practices regarding adult immunizations is ideal. Using these models combined with a multidisciplinary research team and triangulation of data collection, we hope to gain insight into factors associated with adult immunizations. Authorities have suggested that a tailored approach that accounts for the core values, structure, and internal operations of practices, is more likely to raise immunization rates than using the same approach for all practices.11,15,16 This unique study design allows for simultaneous examination of patient, provider, and office culture factors and their relative impact on adult immunization rates. This in turn will facilitate the development of tailored intervention plans to improve those rates.
Acknowledgments
This publication/project was funded by HS09874-01A1 from the Agency for Healthcare Research and Quality. The authors wish to acknowledge Michael J. Fine, MD; Edmund M. Ricci, PhD; Seymour Grufferman, MD; Ilene K. Jewell, MS Hyg; and Mahlon Raymund, PhD, for their significant contributions to the design and implementation of this project or paper.
1. Centers for Disease Control and Prevention. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morbid Mortal Wkly Rep 2000;49:1-38.
2. Centers for Disease Control and Prevention. Prevention of pneumococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morbid Mortal Wkly Rep 1997;46:1-24.
3. Centers for Disease Control and Prevention. Active bacterial core surveillance (ABCs) report, Emerging Infections Program Network, Streptococcus pneumoniae, 1998. Atlanta, Ga: Emerging Infections Program Network; 1998.
4. Nuorti JP, Butler JC, Farley MM, et al. Cigarette smoking and invasive pneumococcal disease. N Eng J Med 2000;342:681-89.
5. Fine MJ, Smith MA, Carson CA, et al. Efficacy of pneumococcal vaccination in adults. Arch Intern Med 1994;154:2666-77.
6. Demicheli V, Jefferson T, Rivetti D, Deeks J. Prevention and early treatment of influenza in healthy adults. Vaccine 2000;18:957-1030.
7. Nichol KL, Margolis KL, Wuorenma J, Von Sternberg TL. The efficacy and cost effectiveness of vaccination against influenza among elderly persons living in the community. N Engl J Med 1994;331:778-84.
8. Centers for Disease Control and Prevention. Influenza and pneumococcal vaccination levels among adults aged greater than or equal to 65 years—United States. MMWR Morbid Mortal Wkly Rep 1998;47:797-802.
9. Gyorkos TW, Tannenbaum TN, Abrahamowicz M, et al. Evaluation of the effectiveness of immunization delivery methods. Can J Public Health—Revue Canadienne De Sante Publique 1994;85(suppl):S14-30.
10. Centers for Disease Control and Prevention. Vaccine-preventable diseases: improving vaccination coverage in children, adolescents, and adults. A report on recommendations of the Task Force on Community Preventive Services. MMWR Morbid Mortal Wkly Rep 1999;48:1-33.
11. McIlvain HE, Crabtree BF, Gilbert C, Havranek R, Backer E. Current trends in tobacco prevention and cessation in Nebraska physicians’ offices. J Fam Pract 1997;44:193-202.
12. Crabtree BF, Miller WL, Aita VA, Flocke SA, Stange KC. Primary care practice organization and preventive services delivery: a qualitative analysis. J Fam Pract 1998;46:403-09.
13. Stange KC, Zyzanski SJ, Jaen CR, et al. Illuminating the ‘black box’: a description of 4454 patient visits to 138 family physicians. J Fam Pract 1998;46:377-89.
14. Miller, Crabtree BF, McDaniel R, Stange KC. Understanding change in primary care practice using complexity theory. J Fam Pract 1998;46:369-76.
15. Greco PJ, Eisenberg JM. Changing physicians’ practices. N Engl J Med 1993;329:1271-73.
16. Carney PA, Dietrich AJ, Keller A, Landgraf J, O’Connor GT. Tools, teamwork, and tenacity: an office system for cancer prevention. J Fam Pract 1992;35:388-94.
17. Centers for Disease Control and Prevention. Reasons reported by Medicare beneficiaries for not receiving influenza and pneumococcal vaccinations—United States, 1996. MMWR Morbid Mortal Wkly Rep 1999;43:886-89.
18. Hutchinson HL, Norma LA. Compliance with influenza immunization: a survey of high-risk patients at a family medicine clinic. J Am Board Fam Pract 1995;8:448-51.
19. Nichol K, MacDonald R, Hauge M. Factors associated with influenza and pneumococcal vaccination behavior among high-risk adults. J Gen Intern Med 1996;11:673-77.
20. Pregliasco F, Sodano L, Mensi C, et al. Influenza vaccination among the elderly in Italy. Bull World Health Org 1999;77:127-31.
21. Fiebach NH, Viscoli CM. Patient acceptance of influenza vaccination. Am J Med 1991;91:393-400.
22. Gene J, Espinola A, Cabezas C, et al. Do knowledge and attitude about influenza and its immunization affect the likelihood of obtaining immunization. Fam Pract Res J 1992;12:61-73.
23. van Essen GA, Kuyvenhoven MM, de Melker RA. Why do healthy elderly people fail to comply with influenza vaccination. Age Ageing 1997;26:275-79.
24. Zyzanski SJ, Stange KC, Lango D, Flocke SA. Trade-offs in high-volume primary care practice. J Fam Pract 1998;46:397-402.
25. Williams WW, Hickson MA, Kane MA, Kendal AP, Spika JS, Hinman AR. Immunization policies and vaccine coverage among adults: the risk for missed opportunities. Ann Intern Med 1988;108:616-25.
26. Pathman DE, Konrad TR, Freed GL, Freeman VA, Koch GG. The awareness-to-adherence model of the steps to clinical guideline compliance. Med Care 1996;34:873-89.
27. Prochaska JO, Redding CA, Evers K. The transitional model and stages of change. In: Glanz K, Lewis FM, Rimer BK, eds. Health behavior and health education. San Francisco, Calif: Jossey-Bass Inc; 1997;60-84.
28. Montano DE. Predicting and understanding influenza vaccination behavior: alternatives to the health belief model. Med Care 1986;24:438-53.
29. Davidson AR, Jaccard JJ, Triandis HC, Morales ML, Diaz-Guerrero R. Cross-cultural model testing: toward a solution of the etic-emic dilemma. Int J Psychol 1976;11:1-13.
30. Valois P, Desharnais R, Godin G. A comparison of the Fishbein and Ajzen and the Triandis attitudinal models for the prediction of exercise intention and behavior. J Behav Med 1988;11:459-72.
31. Landis D, Triandis HC, Adamopoulos J. Habit and behavioral intentions as predictors of social behavior. J Soc Psychol 1978;106:227-37.
32. Gielen AC, McDonald EM. The PRECEDE-PROCEED planning model. In: Glanz K, Lewis FM, Rimer BK, eds. Health behavior and health education: theory, research, and practice. San Francisco, Calif: Jossey-Bass Inc; 1997;359-83.
33. Gilchrist VJ. Key informant interviews. In: Crabtree BF, Miller WL, eds. Doing qualitative research. London, England: Sage Publications; 1992;70-89.
34. Aday LA. Designing and conducting health surveys. San Francisco, Calif: Jossey-Bass Inc; 1989.
35. Silverman M, Ricci EM, Guntinas MJ. Strategies for increasing the rigor of qualitative methods in the evaluation of health care programs. Eval Rev 1990;14:57-74.
36. Crabtree BF, Miller WL. Doing qualitative research. Newbury Park, Calif: Sage Publications, Inc; 1992.
37. Shah BV, Barnwell BG, Bieler GS. SUDAAN user’s manual. Release 7.5. Research Triangle Park, NC: Research Triangle Institute; 1997.
OBJECTIVES: Immunization rates for influenza and pneumococcal vaccines among the elderly (especially minority elderly) are below desired levels. We sought to answer the following 4 questions: (1) What factors explain most missed immunizations? (2) How are patient beliefs and practices regarding adult immunization affected by racial or cultural factors? (3) How are immunizations and patient beliefs affected by physician, organizational, and operational factors? and (4) Based on the relationships identified, can typologies be created that foster the tailoring of interventions to improve immunization rates?
STUDY DESIGN: A multidisciplinary team chose the PRECEDE-PROCEED framework, the Awareness to Adherence model of clinician response to guidelines, and the Triandis model of consumer decision making as the best models to assess barriers to and facilitators of immunization. Our data collection methods included focus groups, face-to-face and telephone interviews, self-administered surveys, site visits, participant observation, and medical record review.
POPULATION: To encounter a broad spectrum of patients, facilities, systems, and interventions, we sampled from 4 strata: (1) inner-city neighborhood health centers, (2) clinics in Veterans Administration facilities, (3) rural practices in a network, and (4) urban/suburban practices in a network. In stage 1, a stratified random cluster sample of 60 primary care clinicians was selected, 15 in each of the strata. In stage 2, a random sample of 15 patients was selected from each clinician’s list of patients, aiming for 900 total interviews.
CONCLUSION: This multicomponent approach is well suited to identifying barriers to and facilitators of adult immunizations among a variety of populations, including the disadvantaged.
- An increase in adult immunization rates requires individualized interventions that account for the organization and culture of each family medicine practice.
- Assessment of the characteristics of a practice depends on a thorough investigation of provider and patient knowledge, attitudes, beliefs and practices regarding immunization.
- The PRECEDE-PROCEED framework using the Awareness to Adherence and Triandis models creates useful theoretical models for evaluating the characteristics of family medicine practices.
- Typologies developed from this procedure may help to simplify the process of characterizing practices and developing individualized immunization interventions.
Together, influenza and pneumonia are the sixth leading cause of death. Each year, influenza causes approximately 20,000 deaths, and pneumococcus causes approximately 500,000 cases of pneumonia, 50,000 cases of bacteremia, and 3000 cases of meningitis.1,2 African Americans experience approximately twice the rate of invasive pneumococcal disease as whites.3,4
Despite the burden of disease and the availability of vaccine guidelines,1,2,5-7 vaccination rates are only modest, though they are slowly rising. In 1997, only 65% and 45% of persons 65 years or older reported receiving influenza and pneumococcal vaccines, respectively.8 Influenza vaccination rates were lower for persons of Hispanic (58%) and non-Hispanic black (50%) origin than for non-Hispanic whites (67%). Pneumococcal vaccination rates were 34% for Hispanics, 30% for non-Hispanic blacks, and 47% for non-Hispanic whites.8
The low rates are surprising, given that there is an abundance of literature reporting successful interventions for increasing immunization rates.9,10 In a meta-analysis, system-oriented interventions (eg, standing orders for nurses) resulted in pooled rate increases of 39% and 45% for influenza and pneumococcal vaccines, respectively.9 Patient-oriented strategies (eg, postcard reminders that influenza or pneumococcal vaccine was due) resulted in increases of 12% and 75%, respectively. Provider-oriented strategies (eg, chart reminders) resulted in increases of 18% and 8%, respectively, for influenza and pneumococcal vaccines.9
Causes of low immunization rates
Although immunization rates are slowly increasing, why have they not risen more, given the evidence of effective interventions? We believe that there are 4 primary reasons why many clinical practices have not successfully applied research findings to improve adult vaccination rates.
First, offices are complex systems with idiosyncratic organization structures and values. They tend to accept changes when they are congruent with the organization’s goals and culture. Most previous efforts at intervention treated practices uniformly, with a “one size fits all” approach.2,11 However, data from the Direct Observation of Primary Care Study reveals a wide variety of patients and problems.12-14 Several authors have recommended tailoring interventions to match the organizational structure, office culture, and individual physician philosophies and practices as a means of increasing the likelihood of success.11,12,15,16
Also, patient beliefs about adult vaccination are varied and include racial and ethnic diversity as well. Significant percentages of the elderly report lack of awareness of the need for immunizations (19% for influenza vaccination and 57% for pneumococcal vaccination).17-19 Among racial groups, non-Hispanic blacks were least aware of the need for these vaccines, followed by Hispanics and non-Hispanic whites.17 Concern that vaccination may actually cause disease17,20 and fear of the pain of injection and/or needles17,21,22 lead many to decline vaccination. Although serious adverse events due to vaccination are rare, media attention to them increases public awareness of their occurrence and may contribute to fear of adverse reactions.17,20-23
Time pressures on physicians also distract attention from prevention. Zyzanski and colleagues24 found that physicians seeing high volumes of patients, in comparison to those with low volumes, had visits that were 30% shorter, scheduled fewer patients for well-care visits, delivered fewer preventive screenings, and gave fewer immunizations.
Finally, the responsibility for adult immunization has not been definitively assigned, resulting in fewer programmatic efforts. Many groups have an interest in adult immunization; however, coordination is limited, causing immunization messages to become diffuse. As a result, many providers caring for adults do not see vaccination as their responsibility.
The cumulative effect of these factors is that, despite access to medical care, many of the adults at high risk for vaccine-preventable diseases remain unvaccinated.25
Research Questions
- Several research questions emerge from this scenario:
- What are the influenza and pneumococcal vaccination rates among persons 65 years and older of both majority and minority populations?
- What are the internal structure and office culture of various medical practices, and how do they facilitate or inhibit adult immunizations?
- What are providers’ attitudes, knowledge, and practices regarding adult immunizations?
- What are patients’ attitudes, knowledge, and beliefs regarding influenza and pneumococcal immunizations?
- What are the relationships among patient and provider knowledge, attitudes, beliefs, and practices and their impact on adult influenza and pneumococcal immunization rates?
- To answer these questions, a large multicomponent study with a variety of physician practice types and patient populations is required. Also, both quantitative and qualitative data need to be collected. In this article, we will describe the development of the methods used to answer these research questions.
Methods
Theoretical Framework and Models
To design our questionnaires, we used data from the literature, observations of the investigators, and 2 theoretical models: the Awareness to Adherence physician decision-making model and the Triandis consumer decision-making model.
The Awareness to Adherence model was developed to understand how physicians comply with new national practice guidelines for hepatitis B.26 It was chosen because it is perhaps the only theoretical model that has both been designed and tested to explain the vaccination behavior of clinicians. This model includes 4 sequential cognitive and behavioral steps: awareness, agreement, adoption, and adherence. It is similar to the Stages of Change model of precontemplation, contemplation, preparation, action, and maintenance.27 Shortly after national recommendations for hepatitis B vaccination of all infants, 98% of physicians were aware of them; 70% agreed with them; 55% adopted them; and 30% adhered to them.26 Interventions to improve compliance with any given recommendation can fail if the specific problem of either awareness, agreement, adoption, or adherence is not identified and addressed. For example, efforts at further dissemination are the most common type of intervention to increase compliance, but in the case of hepatitis B vaccinations for children, 98% of physicians were aware of the guidelines. Therefore, further attempts to increase physicians’ awareness would be unlikely to increase vaccination rates.
The Triandis model has been used to understand consumer decision making and is based on the theory of reasoned action. We chose it for several reasons. First, The Triandis model as used for influenza immunization is internally consistent (Chronbach a = .91) and has been externally validated.28 Second, it is broader than earlier models in that it accounts not only for beliefs, but also for values, social networks, habits, and physician influence on patients. Third, the Triandis model is able to predict behavior in a variety of cultural and economic situations.28-31
Although these 2 models capture behavioral and educational issues related to health practices, they miss systemwide interventions such as standing orders that have had a major impact in raising immunization rates. Thus, we sought a larger framework that was comprehensive, would allow us to incorporate behaviorally oriented models as well as system interventions, and would facilitate the development of interventions. We chose the PRECEDE-PROCEED framework, a systematic process to evaluate health problems and design intervention programs.32 PRECEDE, an acronym for the Predisposing, Reinforcing, and Enabling Constructs in Educational Diagnosis and Evaluation, is an educational diagnosis model developed in the 1970s. PROCEED, an acronym for Policy, Regulatory, and Organizational Constructs in Educational and Environmental Development, was added to the model in 1991.32 PRECEDE-PROCEED offers specific guidelines for analysis of target populations so that the appropriateness of specific interventions can be determined.32 Although not a theory itself, PRECEDE-PROCEED provides a framework for applying theories. A key element of this framework is participation by the population in defining its problems and goals (Phase 1). In Phase 2, an epidemiologic diagnosis sets priorities for the community’s health problems so that resources can be applied to interventions that will have the most impact. Phase 3 is the behavioral and environmental diagnosis that helps planners determine risk factors for a particular problem and which of those risk factors are amenable to change. Phase 4, the educational and organizational diagnosis, enables planners to determine the predisposing, reinforcing, and enabling factors that influence the likelihood that behavioral and environmental change will occur. Those factors within an organization that have the capacity to facilitate or hinder the implementation of a program are determined in Phase 5 Figure 1. Phase 6 is the implementation phase, and Phases 7 to 9 comprise the evaluations of the process, impact, and outcome of the intervention program.
Triangulation
We also employed triangulation, a process that assesses the problem from multiple vantage points using multiple data collection techniques and multiple data sources Table 1.33 The vantage points from which we collected data were the patient, the health care provider, and the health care organization. Our data collection techniques included focus groups, face-to-face and telephone interviews, self-administered surveys, site visits, participant observation, and medical record review. These methods provided data that are both quantitative (eg, immunization histories, demographics, surveys) and qualitative (eg, participant observations and focus group findings). Table 2 shows the relationships of the theoretical models and the specific research questions.
Conducting a study that collects both quantitative and qualitative methods requires the expertise of a multidisciplinary team. Our team included members from the disciplines of family medicine, preventive medicine, public health, internal medicine, medical sociology, medical anthropology, geriatrics, epidemiology, survey research, and biostatistics. This diversity in research backgrounds further broadens the perspective of the project.
Nested Sampling Design
The barriers to and facilitators of immunizations likely vary by characteristics of the patient population, by the mission of the health care facility, by the beliefs of the physicians, and by its internal operations and policies. We selected 4 types of facilities as our 4 strata to ensure access to a broad spectrum of patients, facilities, and policies, including: (1) inner-city neighborhood health centers serving economically disadvantaged populations with a high proportion of African American patients, (2) clinics in a Veterans Administration facility that also provides care for the underserved and which has an institutionwide program for increasing influenza and pneumococcal vaccination rates, (3) rural practices in a network, and (4) urban/suburban practices in a network.
A 2-stage stratified random cluster sampling was conducted to select participants. In stage 1, a stratified random cluster sample of 60 primary care clinicians (physicians, physician assistants, or nurse practitioners) was selected, 15 in each of the 4 strata. In stage 2, a randomly selected list of patients 66 years and older and seen in the office on or after October 1, 1998, was developed for each clinician. A random sample of 22 patients was then selected from each of these lists, with a target of 15 completed patient interviews per clinician. A total of 900 (60*15) patient interviews was the goal. This design allowed us to assess relationships among patient beliefs and behaviors, clinician beliefs and behaviors, and office systems and immunization records.
IRB Approval
This study was reviewed and approved by the Institutional Review Board of the University of Pittsburgh and the Human Use Subcommittee of the Institutional Review Board of the Veterans Affairs Healthcare System of Pittsburgh.
Data Collection
Seven survey instruments were used, 4 (1 each for physicians, nurses, office managers, and those patients followed by the anthropologists) were self-administered questionnaires of 19 to 59 items, primarily using scales and other quantitative measures. Three (1 each for physicians, nurses, and patients) were questionnaires used in face-to-face or telephone interviews that included open-ended questions.
All instruments were developed in a lengthy process of internal review and revision. The final drafts were piloted locally—the provider instruments on practicing primary care physicians, nurse practitioners, and nurses, and the patient instrument on visitors to a local senior citizen center. Subsequently, revisions were made.
Between July 1999 and December 1999, members of the research team visited each of the participating practices to further explain the project, photograph the office physical environment, collect floor plans, collect patient immunization related materials, distribute self-administered questionnaires, and complete as many face-to-face interviews as feasible.
On completion of the provider surveys and office visits, the patient telephone survey was initiated. To encourage patient participation, an endorsement letter from the clinician on practice stationery was mailed to patients, and they were offered a $20 honorarium. The patient questionnaire was programmed for computer-assisted telephone interviewing (CATI). CATI permits direct data entry during the interview, manages the sample of persons to be contacted, directs the sequence of questions, eliminates unintentionally skipped questions, and provides automatic range and logic checks.34 Subsequently, medical records were reviewed using a standard form to collect information on immunization and other preventive services and to verify patient reported immunization status.
Participant/Practice Observation
On a subsample of the large study, we pursued a participant/practice observation study, in which 8 of the 24 practices were recruited, 2 from each of the 4 strata. Within the strata, an attempt was made to select 2 diverse practices, based on the number of clinicians, clinician sex, and clinician-to-patient ratio. An additional site was selected for pilot testing of the methodology.
Selected practices were divided between 2 trained anthropologists who spent 2 full workdays at each of their assigned sites. Following a prescribed protocol, their task was to observe the office practice, the interpersonal styles of the clinicians, and the office environment and culture. They also observed provider-patient interactions for 3 to 5 patients per practice and interviewed the patients following their examinations to assess their overall satisfaction and experience with the clinic. Also, the team reviewed information obtained from the face-to-face interviews of clinicians and nurses.
A systematic process of review of all observations occurred throughout the data collection to insure the trustworthiness of these data based on techniques used by Silverman and coworkers.35 The first level of review was to discuss all observations among the 3 anthropologists following the collection of observation data of each site. This served to identify gaps in the data collection or areas where observations required some confirmation for accuracy and interpretation. The second level of review was through discussions at the weekly research team meetings for data verification and clarification of interpretation. Finally, the 8 sites were classified into types based on similarities in organizational structure, operational characteristics, and physician and staff philosophy.
Focus Groups
Two focus groups were held with senior adults who were not among the patients participating in the study. One group consisted of 14 African Americans, and the other consisted of 10 whites; both sexes were represented. Participants were recruited through a local senior center, where the focus groups were conducted. Discussion addressed issues of barriers to and facilitators of immunization and recommendations for improving immunization rates.
Statistical Methods
Qualitative data analysis methods such as the creation of code books was used to categorize the provider and staff responses to the interviewer questions and participant observations. These categorized responses were then used in the quantitative analysis in both bivariate and logistic regression models.36
The quantitative analysis of the data must take into account the cluster-correlated nature of the data which results from a complex multistage stratified clustered sampling strategy. For this reason, we used statistical software that can compute standard errors, regression coefficients, and other statistics in accordance with the sample design.37 Frequencies of patient responses to questions were computed using both quantitative and coded qualitative items. Bivariate relationships were examined, followed by logistic regression modeling, with receipt versus nonreceipt of vaccines as the dependent variable. Models were developed for each of the influenza and pneumococcal vaccines as dependent variables.
Discussion
Relevance of This Methodology for Future Interventions
The application of the PRECEDE-PROCEED framework and Awareness to Adherence and Triandis models to the study of provider and patient attitudes, knowledge, beliefs, and practices regarding adult immunizations is ideal. Using these models combined with a multidisciplinary research team and triangulation of data collection, we hope to gain insight into factors associated with adult immunizations. Authorities have suggested that a tailored approach that accounts for the core values, structure, and internal operations of practices, is more likely to raise immunization rates than using the same approach for all practices.11,15,16 This unique study design allows for simultaneous examination of patient, provider, and office culture factors and their relative impact on adult immunization rates. This in turn will facilitate the development of tailored intervention plans to improve those rates.
Acknowledgments
This publication/project was funded by HS09874-01A1 from the Agency for Healthcare Research and Quality. The authors wish to acknowledge Michael J. Fine, MD; Edmund M. Ricci, PhD; Seymour Grufferman, MD; Ilene K. Jewell, MS Hyg; and Mahlon Raymund, PhD, for their significant contributions to the design and implementation of this project or paper.
OBJECTIVES: Immunization rates for influenza and pneumococcal vaccines among the elderly (especially minority elderly) are below desired levels. We sought to answer the following 4 questions: (1) What factors explain most missed immunizations? (2) How are patient beliefs and practices regarding adult immunization affected by racial or cultural factors? (3) How are immunizations and patient beliefs affected by physician, organizational, and operational factors? and (4) Based on the relationships identified, can typologies be created that foster the tailoring of interventions to improve immunization rates?
STUDY DESIGN: A multidisciplinary team chose the PRECEDE-PROCEED framework, the Awareness to Adherence model of clinician response to guidelines, and the Triandis model of consumer decision making as the best models to assess barriers to and facilitators of immunization. Our data collection methods included focus groups, face-to-face and telephone interviews, self-administered surveys, site visits, participant observation, and medical record review.
POPULATION: To encounter a broad spectrum of patients, facilities, systems, and interventions, we sampled from 4 strata: (1) inner-city neighborhood health centers, (2) clinics in Veterans Administration facilities, (3) rural practices in a network, and (4) urban/suburban practices in a network. In stage 1, a stratified random cluster sample of 60 primary care clinicians was selected, 15 in each of the strata. In stage 2, a random sample of 15 patients was selected from each clinician’s list of patients, aiming for 900 total interviews.
CONCLUSION: This multicomponent approach is well suited to identifying barriers to and facilitators of adult immunizations among a variety of populations, including the disadvantaged.
- An increase in adult immunization rates requires individualized interventions that account for the organization and culture of each family medicine practice.
- Assessment of the characteristics of a practice depends on a thorough investigation of provider and patient knowledge, attitudes, beliefs and practices regarding immunization.
- The PRECEDE-PROCEED framework using the Awareness to Adherence and Triandis models creates useful theoretical models for evaluating the characteristics of family medicine practices.
- Typologies developed from this procedure may help to simplify the process of characterizing practices and developing individualized immunization interventions.
Together, influenza and pneumonia are the sixth leading cause of death. Each year, influenza causes approximately 20,000 deaths, and pneumococcus causes approximately 500,000 cases of pneumonia, 50,000 cases of bacteremia, and 3000 cases of meningitis.1,2 African Americans experience approximately twice the rate of invasive pneumococcal disease as whites.3,4
Despite the burden of disease and the availability of vaccine guidelines,1,2,5-7 vaccination rates are only modest, though they are slowly rising. In 1997, only 65% and 45% of persons 65 years or older reported receiving influenza and pneumococcal vaccines, respectively.8 Influenza vaccination rates were lower for persons of Hispanic (58%) and non-Hispanic black (50%) origin than for non-Hispanic whites (67%). Pneumococcal vaccination rates were 34% for Hispanics, 30% for non-Hispanic blacks, and 47% for non-Hispanic whites.8
The low rates are surprising, given that there is an abundance of literature reporting successful interventions for increasing immunization rates.9,10 In a meta-analysis, system-oriented interventions (eg, standing orders for nurses) resulted in pooled rate increases of 39% and 45% for influenza and pneumococcal vaccines, respectively.9 Patient-oriented strategies (eg, postcard reminders that influenza or pneumococcal vaccine was due) resulted in increases of 12% and 75%, respectively. Provider-oriented strategies (eg, chart reminders) resulted in increases of 18% and 8%, respectively, for influenza and pneumococcal vaccines.9
Causes of low immunization rates
Although immunization rates are slowly increasing, why have they not risen more, given the evidence of effective interventions? We believe that there are 4 primary reasons why many clinical practices have not successfully applied research findings to improve adult vaccination rates.
First, offices are complex systems with idiosyncratic organization structures and values. They tend to accept changes when they are congruent with the organization’s goals and culture. Most previous efforts at intervention treated practices uniformly, with a “one size fits all” approach.2,11 However, data from the Direct Observation of Primary Care Study reveals a wide variety of patients and problems.12-14 Several authors have recommended tailoring interventions to match the organizational structure, office culture, and individual physician philosophies and practices as a means of increasing the likelihood of success.11,12,15,16
Also, patient beliefs about adult vaccination are varied and include racial and ethnic diversity as well. Significant percentages of the elderly report lack of awareness of the need for immunizations (19% for influenza vaccination and 57% for pneumococcal vaccination).17-19 Among racial groups, non-Hispanic blacks were least aware of the need for these vaccines, followed by Hispanics and non-Hispanic whites.17 Concern that vaccination may actually cause disease17,20 and fear of the pain of injection and/or needles17,21,22 lead many to decline vaccination. Although serious adverse events due to vaccination are rare, media attention to them increases public awareness of their occurrence and may contribute to fear of adverse reactions.17,20-23
Time pressures on physicians also distract attention from prevention. Zyzanski and colleagues24 found that physicians seeing high volumes of patients, in comparison to those with low volumes, had visits that were 30% shorter, scheduled fewer patients for well-care visits, delivered fewer preventive screenings, and gave fewer immunizations.
Finally, the responsibility for adult immunization has not been definitively assigned, resulting in fewer programmatic efforts. Many groups have an interest in adult immunization; however, coordination is limited, causing immunization messages to become diffuse. As a result, many providers caring for adults do not see vaccination as their responsibility.
The cumulative effect of these factors is that, despite access to medical care, many of the adults at high risk for vaccine-preventable diseases remain unvaccinated.25
Research Questions
- Several research questions emerge from this scenario:
- What are the influenza and pneumococcal vaccination rates among persons 65 years and older of both majority and minority populations?
- What are the internal structure and office culture of various medical practices, and how do they facilitate or inhibit adult immunizations?
- What are providers’ attitudes, knowledge, and practices regarding adult immunizations?
- What are patients’ attitudes, knowledge, and beliefs regarding influenza and pneumococcal immunizations?
- What are the relationships among patient and provider knowledge, attitudes, beliefs, and practices and their impact on adult influenza and pneumococcal immunization rates?
- To answer these questions, a large multicomponent study with a variety of physician practice types and patient populations is required. Also, both quantitative and qualitative data need to be collected. In this article, we will describe the development of the methods used to answer these research questions.
Methods
Theoretical Framework and Models
To design our questionnaires, we used data from the literature, observations of the investigators, and 2 theoretical models: the Awareness to Adherence physician decision-making model and the Triandis consumer decision-making model.
The Awareness to Adherence model was developed to understand how physicians comply with new national practice guidelines for hepatitis B.26 It was chosen because it is perhaps the only theoretical model that has both been designed and tested to explain the vaccination behavior of clinicians. This model includes 4 sequential cognitive and behavioral steps: awareness, agreement, adoption, and adherence. It is similar to the Stages of Change model of precontemplation, contemplation, preparation, action, and maintenance.27 Shortly after national recommendations for hepatitis B vaccination of all infants, 98% of physicians were aware of them; 70% agreed with them; 55% adopted them; and 30% adhered to them.26 Interventions to improve compliance with any given recommendation can fail if the specific problem of either awareness, agreement, adoption, or adherence is not identified and addressed. For example, efforts at further dissemination are the most common type of intervention to increase compliance, but in the case of hepatitis B vaccinations for children, 98% of physicians were aware of the guidelines. Therefore, further attempts to increase physicians’ awareness would be unlikely to increase vaccination rates.
The Triandis model has been used to understand consumer decision making and is based on the theory of reasoned action. We chose it for several reasons. First, The Triandis model as used for influenza immunization is internally consistent (Chronbach a = .91) and has been externally validated.28 Second, it is broader than earlier models in that it accounts not only for beliefs, but also for values, social networks, habits, and physician influence on patients. Third, the Triandis model is able to predict behavior in a variety of cultural and economic situations.28-31
Although these 2 models capture behavioral and educational issues related to health practices, they miss systemwide interventions such as standing orders that have had a major impact in raising immunization rates. Thus, we sought a larger framework that was comprehensive, would allow us to incorporate behaviorally oriented models as well as system interventions, and would facilitate the development of interventions. We chose the PRECEDE-PROCEED framework, a systematic process to evaluate health problems and design intervention programs.32 PRECEDE, an acronym for the Predisposing, Reinforcing, and Enabling Constructs in Educational Diagnosis and Evaluation, is an educational diagnosis model developed in the 1970s. PROCEED, an acronym for Policy, Regulatory, and Organizational Constructs in Educational and Environmental Development, was added to the model in 1991.32 PRECEDE-PROCEED offers specific guidelines for analysis of target populations so that the appropriateness of specific interventions can be determined.32 Although not a theory itself, PRECEDE-PROCEED provides a framework for applying theories. A key element of this framework is participation by the population in defining its problems and goals (Phase 1). In Phase 2, an epidemiologic diagnosis sets priorities for the community’s health problems so that resources can be applied to interventions that will have the most impact. Phase 3 is the behavioral and environmental diagnosis that helps planners determine risk factors for a particular problem and which of those risk factors are amenable to change. Phase 4, the educational and organizational diagnosis, enables planners to determine the predisposing, reinforcing, and enabling factors that influence the likelihood that behavioral and environmental change will occur. Those factors within an organization that have the capacity to facilitate or hinder the implementation of a program are determined in Phase 5 Figure 1. Phase 6 is the implementation phase, and Phases 7 to 9 comprise the evaluations of the process, impact, and outcome of the intervention program.
Triangulation
We also employed triangulation, a process that assesses the problem from multiple vantage points using multiple data collection techniques and multiple data sources Table 1.33 The vantage points from which we collected data were the patient, the health care provider, and the health care organization. Our data collection techniques included focus groups, face-to-face and telephone interviews, self-administered surveys, site visits, participant observation, and medical record review. These methods provided data that are both quantitative (eg, immunization histories, demographics, surveys) and qualitative (eg, participant observations and focus group findings). Table 2 shows the relationships of the theoretical models and the specific research questions.
Conducting a study that collects both quantitative and qualitative methods requires the expertise of a multidisciplinary team. Our team included members from the disciplines of family medicine, preventive medicine, public health, internal medicine, medical sociology, medical anthropology, geriatrics, epidemiology, survey research, and biostatistics. This diversity in research backgrounds further broadens the perspective of the project.
Nested Sampling Design
The barriers to and facilitators of immunizations likely vary by characteristics of the patient population, by the mission of the health care facility, by the beliefs of the physicians, and by its internal operations and policies. We selected 4 types of facilities as our 4 strata to ensure access to a broad spectrum of patients, facilities, and policies, including: (1) inner-city neighborhood health centers serving economically disadvantaged populations with a high proportion of African American patients, (2) clinics in a Veterans Administration facility that also provides care for the underserved and which has an institutionwide program for increasing influenza and pneumococcal vaccination rates, (3) rural practices in a network, and (4) urban/suburban practices in a network.
A 2-stage stratified random cluster sampling was conducted to select participants. In stage 1, a stratified random cluster sample of 60 primary care clinicians (physicians, physician assistants, or nurse practitioners) was selected, 15 in each of the 4 strata. In stage 2, a randomly selected list of patients 66 years and older and seen in the office on or after October 1, 1998, was developed for each clinician. A random sample of 22 patients was then selected from each of these lists, with a target of 15 completed patient interviews per clinician. A total of 900 (60*15) patient interviews was the goal. This design allowed us to assess relationships among patient beliefs and behaviors, clinician beliefs and behaviors, and office systems and immunization records.
IRB Approval
This study was reviewed and approved by the Institutional Review Board of the University of Pittsburgh and the Human Use Subcommittee of the Institutional Review Board of the Veterans Affairs Healthcare System of Pittsburgh.
Data Collection
Seven survey instruments were used, 4 (1 each for physicians, nurses, office managers, and those patients followed by the anthropologists) were self-administered questionnaires of 19 to 59 items, primarily using scales and other quantitative measures. Three (1 each for physicians, nurses, and patients) were questionnaires used in face-to-face or telephone interviews that included open-ended questions.
All instruments were developed in a lengthy process of internal review and revision. The final drafts were piloted locally—the provider instruments on practicing primary care physicians, nurse practitioners, and nurses, and the patient instrument on visitors to a local senior citizen center. Subsequently, revisions were made.
Between July 1999 and December 1999, members of the research team visited each of the participating practices to further explain the project, photograph the office physical environment, collect floor plans, collect patient immunization related materials, distribute self-administered questionnaires, and complete as many face-to-face interviews as feasible.
On completion of the provider surveys and office visits, the patient telephone survey was initiated. To encourage patient participation, an endorsement letter from the clinician on practice stationery was mailed to patients, and they were offered a $20 honorarium. The patient questionnaire was programmed for computer-assisted telephone interviewing (CATI). CATI permits direct data entry during the interview, manages the sample of persons to be contacted, directs the sequence of questions, eliminates unintentionally skipped questions, and provides automatic range and logic checks.34 Subsequently, medical records were reviewed using a standard form to collect information on immunization and other preventive services and to verify patient reported immunization status.
Participant/Practice Observation
On a subsample of the large study, we pursued a participant/practice observation study, in which 8 of the 24 practices were recruited, 2 from each of the 4 strata. Within the strata, an attempt was made to select 2 diverse practices, based on the number of clinicians, clinician sex, and clinician-to-patient ratio. An additional site was selected for pilot testing of the methodology.
Selected practices were divided between 2 trained anthropologists who spent 2 full workdays at each of their assigned sites. Following a prescribed protocol, their task was to observe the office practice, the interpersonal styles of the clinicians, and the office environment and culture. They also observed provider-patient interactions for 3 to 5 patients per practice and interviewed the patients following their examinations to assess their overall satisfaction and experience with the clinic. Also, the team reviewed information obtained from the face-to-face interviews of clinicians and nurses.
A systematic process of review of all observations occurred throughout the data collection to insure the trustworthiness of these data based on techniques used by Silverman and coworkers.35 The first level of review was to discuss all observations among the 3 anthropologists following the collection of observation data of each site. This served to identify gaps in the data collection or areas where observations required some confirmation for accuracy and interpretation. The second level of review was through discussions at the weekly research team meetings for data verification and clarification of interpretation. Finally, the 8 sites were classified into types based on similarities in organizational structure, operational characteristics, and physician and staff philosophy.
Focus Groups
Two focus groups were held with senior adults who were not among the patients participating in the study. One group consisted of 14 African Americans, and the other consisted of 10 whites; both sexes were represented. Participants were recruited through a local senior center, where the focus groups were conducted. Discussion addressed issues of barriers to and facilitators of immunization and recommendations for improving immunization rates.
Statistical Methods
Qualitative data analysis methods such as the creation of code books was used to categorize the provider and staff responses to the interviewer questions and participant observations. These categorized responses were then used in the quantitative analysis in both bivariate and logistic regression models.36
The quantitative analysis of the data must take into account the cluster-correlated nature of the data which results from a complex multistage stratified clustered sampling strategy. For this reason, we used statistical software that can compute standard errors, regression coefficients, and other statistics in accordance with the sample design.37 Frequencies of patient responses to questions were computed using both quantitative and coded qualitative items. Bivariate relationships were examined, followed by logistic regression modeling, with receipt versus nonreceipt of vaccines as the dependent variable. Models were developed for each of the influenza and pneumococcal vaccines as dependent variables.
Discussion
Relevance of This Methodology for Future Interventions
The application of the PRECEDE-PROCEED framework and Awareness to Adherence and Triandis models to the study of provider and patient attitudes, knowledge, beliefs, and practices regarding adult immunizations is ideal. Using these models combined with a multidisciplinary research team and triangulation of data collection, we hope to gain insight into factors associated with adult immunizations. Authorities have suggested that a tailored approach that accounts for the core values, structure, and internal operations of practices, is more likely to raise immunization rates than using the same approach for all practices.11,15,16 This unique study design allows for simultaneous examination of patient, provider, and office culture factors and their relative impact on adult immunization rates. This in turn will facilitate the development of tailored intervention plans to improve those rates.
Acknowledgments
This publication/project was funded by HS09874-01A1 from the Agency for Healthcare Research and Quality. The authors wish to acknowledge Michael J. Fine, MD; Edmund M. Ricci, PhD; Seymour Grufferman, MD; Ilene K. Jewell, MS Hyg; and Mahlon Raymund, PhD, for their significant contributions to the design and implementation of this project or paper.
1. Centers for Disease Control and Prevention. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morbid Mortal Wkly Rep 2000;49:1-38.
2. Centers for Disease Control and Prevention. Prevention of pneumococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morbid Mortal Wkly Rep 1997;46:1-24.
3. Centers for Disease Control and Prevention. Active bacterial core surveillance (ABCs) report, Emerging Infections Program Network, Streptococcus pneumoniae, 1998. Atlanta, Ga: Emerging Infections Program Network; 1998.
4. Nuorti JP, Butler JC, Farley MM, et al. Cigarette smoking and invasive pneumococcal disease. N Eng J Med 2000;342:681-89.
5. Fine MJ, Smith MA, Carson CA, et al. Efficacy of pneumococcal vaccination in adults. Arch Intern Med 1994;154:2666-77.
6. Demicheli V, Jefferson T, Rivetti D, Deeks J. Prevention and early treatment of influenza in healthy adults. Vaccine 2000;18:957-1030.
7. Nichol KL, Margolis KL, Wuorenma J, Von Sternberg TL. The efficacy and cost effectiveness of vaccination against influenza among elderly persons living in the community. N Engl J Med 1994;331:778-84.
8. Centers for Disease Control and Prevention. Influenza and pneumococcal vaccination levels among adults aged greater than or equal to 65 years—United States. MMWR Morbid Mortal Wkly Rep 1998;47:797-802.
9. Gyorkos TW, Tannenbaum TN, Abrahamowicz M, et al. Evaluation of the effectiveness of immunization delivery methods. Can J Public Health—Revue Canadienne De Sante Publique 1994;85(suppl):S14-30.
10. Centers for Disease Control and Prevention. Vaccine-preventable diseases: improving vaccination coverage in children, adolescents, and adults. A report on recommendations of the Task Force on Community Preventive Services. MMWR Morbid Mortal Wkly Rep 1999;48:1-33.
11. McIlvain HE, Crabtree BF, Gilbert C, Havranek R, Backer E. Current trends in tobacco prevention and cessation in Nebraska physicians’ offices. J Fam Pract 1997;44:193-202.
12. Crabtree BF, Miller WL, Aita VA, Flocke SA, Stange KC. Primary care practice organization and preventive services delivery: a qualitative analysis. J Fam Pract 1998;46:403-09.
13. Stange KC, Zyzanski SJ, Jaen CR, et al. Illuminating the ‘black box’: a description of 4454 patient visits to 138 family physicians. J Fam Pract 1998;46:377-89.
14. Miller, Crabtree BF, McDaniel R, Stange KC. Understanding change in primary care practice using complexity theory. J Fam Pract 1998;46:369-76.
15. Greco PJ, Eisenberg JM. Changing physicians’ practices. N Engl J Med 1993;329:1271-73.
16. Carney PA, Dietrich AJ, Keller A, Landgraf J, O’Connor GT. Tools, teamwork, and tenacity: an office system for cancer prevention. J Fam Pract 1992;35:388-94.
17. Centers for Disease Control and Prevention. Reasons reported by Medicare beneficiaries for not receiving influenza and pneumococcal vaccinations—United States, 1996. MMWR Morbid Mortal Wkly Rep 1999;43:886-89.
18. Hutchinson HL, Norma LA. Compliance with influenza immunization: a survey of high-risk patients at a family medicine clinic. J Am Board Fam Pract 1995;8:448-51.
19. Nichol K, MacDonald R, Hauge M. Factors associated with influenza and pneumococcal vaccination behavior among high-risk adults. J Gen Intern Med 1996;11:673-77.
20. Pregliasco F, Sodano L, Mensi C, et al. Influenza vaccination among the elderly in Italy. Bull World Health Org 1999;77:127-31.
21. Fiebach NH, Viscoli CM. Patient acceptance of influenza vaccination. Am J Med 1991;91:393-400.
22. Gene J, Espinola A, Cabezas C, et al. Do knowledge and attitude about influenza and its immunization affect the likelihood of obtaining immunization. Fam Pract Res J 1992;12:61-73.
23. van Essen GA, Kuyvenhoven MM, de Melker RA. Why do healthy elderly people fail to comply with influenza vaccination. Age Ageing 1997;26:275-79.
24. Zyzanski SJ, Stange KC, Lango D, Flocke SA. Trade-offs in high-volume primary care practice. J Fam Pract 1998;46:397-402.
25. Williams WW, Hickson MA, Kane MA, Kendal AP, Spika JS, Hinman AR. Immunization policies and vaccine coverage among adults: the risk for missed opportunities. Ann Intern Med 1988;108:616-25.
26. Pathman DE, Konrad TR, Freed GL, Freeman VA, Koch GG. The awareness-to-adherence model of the steps to clinical guideline compliance. Med Care 1996;34:873-89.
27. Prochaska JO, Redding CA, Evers K. The transitional model and stages of change. In: Glanz K, Lewis FM, Rimer BK, eds. Health behavior and health education. San Francisco, Calif: Jossey-Bass Inc; 1997;60-84.
28. Montano DE. Predicting and understanding influenza vaccination behavior: alternatives to the health belief model. Med Care 1986;24:438-53.
29. Davidson AR, Jaccard JJ, Triandis HC, Morales ML, Diaz-Guerrero R. Cross-cultural model testing: toward a solution of the etic-emic dilemma. Int J Psychol 1976;11:1-13.
30. Valois P, Desharnais R, Godin G. A comparison of the Fishbein and Ajzen and the Triandis attitudinal models for the prediction of exercise intention and behavior. J Behav Med 1988;11:459-72.
31. Landis D, Triandis HC, Adamopoulos J. Habit and behavioral intentions as predictors of social behavior. J Soc Psychol 1978;106:227-37.
32. Gielen AC, McDonald EM. The PRECEDE-PROCEED planning model. In: Glanz K, Lewis FM, Rimer BK, eds. Health behavior and health education: theory, research, and practice. San Francisco, Calif: Jossey-Bass Inc; 1997;359-83.
33. Gilchrist VJ. Key informant interviews. In: Crabtree BF, Miller WL, eds. Doing qualitative research. London, England: Sage Publications; 1992;70-89.
34. Aday LA. Designing and conducting health surveys. San Francisco, Calif: Jossey-Bass Inc; 1989.
35. Silverman M, Ricci EM, Guntinas MJ. Strategies for increasing the rigor of qualitative methods in the evaluation of health care programs. Eval Rev 1990;14:57-74.
36. Crabtree BF, Miller WL. Doing qualitative research. Newbury Park, Calif: Sage Publications, Inc; 1992.
37. Shah BV, Barnwell BG, Bieler GS. SUDAAN user’s manual. Release 7.5. Research Triangle Park, NC: Research Triangle Institute; 1997.
1. Centers for Disease Control and Prevention. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morbid Mortal Wkly Rep 2000;49:1-38.
2. Centers for Disease Control and Prevention. Prevention of pneumococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morbid Mortal Wkly Rep 1997;46:1-24.
3. Centers for Disease Control and Prevention. Active bacterial core surveillance (ABCs) report, Emerging Infections Program Network, Streptococcus pneumoniae, 1998. Atlanta, Ga: Emerging Infections Program Network; 1998.
4. Nuorti JP, Butler JC, Farley MM, et al. Cigarette smoking and invasive pneumococcal disease. N Eng J Med 2000;342:681-89.
5. Fine MJ, Smith MA, Carson CA, et al. Efficacy of pneumococcal vaccination in adults. Arch Intern Med 1994;154:2666-77.
6. Demicheli V, Jefferson T, Rivetti D, Deeks J. Prevention and early treatment of influenza in healthy adults. Vaccine 2000;18:957-1030.
7. Nichol KL, Margolis KL, Wuorenma J, Von Sternberg TL. The efficacy and cost effectiveness of vaccination against influenza among elderly persons living in the community. N Engl J Med 1994;331:778-84.
8. Centers for Disease Control and Prevention. Influenza and pneumococcal vaccination levels among adults aged greater than or equal to 65 years—United States. MMWR Morbid Mortal Wkly Rep 1998;47:797-802.
9. Gyorkos TW, Tannenbaum TN, Abrahamowicz M, et al. Evaluation of the effectiveness of immunization delivery methods. Can J Public Health—Revue Canadienne De Sante Publique 1994;85(suppl):S14-30.
10. Centers for Disease Control and Prevention. Vaccine-preventable diseases: improving vaccination coverage in children, adolescents, and adults. A report on recommendations of the Task Force on Community Preventive Services. MMWR Morbid Mortal Wkly Rep 1999;48:1-33.
11. McIlvain HE, Crabtree BF, Gilbert C, Havranek R, Backer E. Current trends in tobacco prevention and cessation in Nebraska physicians’ offices. J Fam Pract 1997;44:193-202.
12. Crabtree BF, Miller WL, Aita VA, Flocke SA, Stange KC. Primary care practice organization and preventive services delivery: a qualitative analysis. J Fam Pract 1998;46:403-09.
13. Stange KC, Zyzanski SJ, Jaen CR, et al. Illuminating the ‘black box’: a description of 4454 patient visits to 138 family physicians. J Fam Pract 1998;46:377-89.
14. Miller, Crabtree BF, McDaniel R, Stange KC. Understanding change in primary care practice using complexity theory. J Fam Pract 1998;46:369-76.
15. Greco PJ, Eisenberg JM. Changing physicians’ practices. N Engl J Med 1993;329:1271-73.
16. Carney PA, Dietrich AJ, Keller A, Landgraf J, O’Connor GT. Tools, teamwork, and tenacity: an office system for cancer prevention. J Fam Pract 1992;35:388-94.
17. Centers for Disease Control and Prevention. Reasons reported by Medicare beneficiaries for not receiving influenza and pneumococcal vaccinations—United States, 1996. MMWR Morbid Mortal Wkly Rep 1999;43:886-89.
18. Hutchinson HL, Norma LA. Compliance with influenza immunization: a survey of high-risk patients at a family medicine clinic. J Am Board Fam Pract 1995;8:448-51.
19. Nichol K, MacDonald R, Hauge M. Factors associated with influenza and pneumococcal vaccination behavior among high-risk adults. J Gen Intern Med 1996;11:673-77.
20. Pregliasco F, Sodano L, Mensi C, et al. Influenza vaccination among the elderly in Italy. Bull World Health Org 1999;77:127-31.
21. Fiebach NH, Viscoli CM. Patient acceptance of influenza vaccination. Am J Med 1991;91:393-400.
22. Gene J, Espinola A, Cabezas C, et al. Do knowledge and attitude about influenza and its immunization affect the likelihood of obtaining immunization. Fam Pract Res J 1992;12:61-73.
23. van Essen GA, Kuyvenhoven MM, de Melker RA. Why do healthy elderly people fail to comply with influenza vaccination. Age Ageing 1997;26:275-79.
24. Zyzanski SJ, Stange KC, Lango D, Flocke SA. Trade-offs in high-volume primary care practice. J Fam Pract 1998;46:397-402.
25. Williams WW, Hickson MA, Kane MA, Kendal AP, Spika JS, Hinman AR. Immunization policies and vaccine coverage among adults: the risk for missed opportunities. Ann Intern Med 1988;108:616-25.
26. Pathman DE, Konrad TR, Freed GL, Freeman VA, Koch GG. The awareness-to-adherence model of the steps to clinical guideline compliance. Med Care 1996;34:873-89.
27. Prochaska JO, Redding CA, Evers K. The transitional model and stages of change. In: Glanz K, Lewis FM, Rimer BK, eds. Health behavior and health education. San Francisco, Calif: Jossey-Bass Inc; 1997;60-84.
28. Montano DE. Predicting and understanding influenza vaccination behavior: alternatives to the health belief model. Med Care 1986;24:438-53.
29. Davidson AR, Jaccard JJ, Triandis HC, Morales ML, Diaz-Guerrero R. Cross-cultural model testing: toward a solution of the etic-emic dilemma. Int J Psychol 1976;11:1-13.
30. Valois P, Desharnais R, Godin G. A comparison of the Fishbein and Ajzen and the Triandis attitudinal models for the prediction of exercise intention and behavior. J Behav Med 1988;11:459-72.
31. Landis D, Triandis HC, Adamopoulos J. Habit and behavioral intentions as predictors of social behavior. J Soc Psychol 1978;106:227-37.
32. Gielen AC, McDonald EM. The PRECEDE-PROCEED planning model. In: Glanz K, Lewis FM, Rimer BK, eds. Health behavior and health education: theory, research, and practice. San Francisco, Calif: Jossey-Bass Inc; 1997;359-83.
33. Gilchrist VJ. Key informant interviews. In: Crabtree BF, Miller WL, eds. Doing qualitative research. London, England: Sage Publications; 1992;70-89.
34. Aday LA. Designing and conducting health surveys. San Francisco, Calif: Jossey-Bass Inc; 1989.
35. Silverman M, Ricci EM, Guntinas MJ. Strategies for increasing the rigor of qualitative methods in the evaluation of health care programs. Eval Rev 1990;14:57-74.
36. Crabtree BF, Miller WL. Doing qualitative research. Newbury Park, Calif: Sage Publications, Inc; 1992.
37. Shah BV, Barnwell BG, Bieler GS. SUDAAN user’s manual. Release 7.5. Research Triangle Park, NC: Research Triangle Institute; 1997.
Time for Changes in Immunization
In this issue of the Journal, Kimmel and colleagues1 report the findings of a valuable study of Ohio family physicians’ and pediatricians’ beliefs about and reported practices of poliovirus immunization. The authors, led by Dr Kimmel, the chairman of the Group on Immunization Education of the Society of Teachers of Family Medicine, found that all physicians were aware of the 1997 poliovirus recommendations, but preferential use of oral poliovirus vaccine (OPV) was related to concerns about the cost of inactivate poliovirus vaccine (IPV) and increased number of injections, while use of the sequential schedule was a reaction to concerns about the risks of vaccine-associated paralytic poliomyelitis (VAPP) and liability.
Kimmel and coworkers found that 63% of family physicians administered OPV, while 67% of pediatricians administered the sequential schedule. Family physicians seem to be more concerned with cost than pediatricians and less concerned with litigation risk; these economic findings parallel findings by other researchers.2,3
One of the main reasons that the American Academy of Family Physicians (AAFP) encouraged parent-provider choice (instead of quickly recommending IPV) was the possibility that the number of injections in the sequential sequence could lead to outbreaks of other vaccine-preventable diseases if immunization rates dropped, especially in disadvantaged areas. The higher cost of IPV was another concern. Also, there was discussion of the importance of intestinal immunity, which is better when OPV is in the schedule. Thus in my opinion, the AAFP position was quite reasonable in 1997. However, in mid- and late 1998 when the price of IPV dropped, and when data became available that showed additional injections of IPV did not have an adverse impact on immunization rates even in disadvantaged communities, the AAFP position appropriately changed.
I believe that the poliovirus vaccine series should start with IPV, and that it makessense to move to the all IPV schedule for the year 2000. I offer several reasons. First, exposure to indigenous wild poliovirus in the United States has ceased. This is because of dramatic progress in poliomyelitis prevention; in 1994 the Americas were declared free of indigenous poliomyelitis, with the last case occurring in 1991 in Peru.4,5 There have been no cases of wild poliomyelitis contracted indigenously in the United States since 1979, and widespread circulation of indigenous wild polioviruses ceased in the 1960s.6 Second, OPV has a slight risk of VAPP, which can occur when the oral vaccine virus reverts to a more virulent form. Of the 125 cases of VAPP reported between 1980 and 1994, the affected individuals were: healthy vaccine recipients (49); healthy contacts of vaccine recipients (40); immunodeficient vaccine recipients (23); immunodeficient contacts of vaccine recipients (7); and community-acquired cases (6).7 VAPP was more common after the first dose of OPV in the all oral vaccine series; 40 of the 49 cases in healthy vaccine recipients occurred after the first dose. The overall risk of VAPP from the all oral vaccine series was 1 case per 2.4 million doses of OPV distributed (125 cases for the 303 million doses of OPV distributed in that time period).7 The risk for the first dose is 1 case per 750,000 first doses distributed. VAPP is paralytic; patients suffer, and their lives are often irreversibly altered. I believe that we can no longer justify the all OPV series in the United States, except in special limited circumstances, such as imminent overseas travel involving an infant. Third, IPV not live, cannot cause poliomyelitis, and thus is safe for immunocompromised patients. Fourth, the majority of parents (61%) prefer to have their child undergo more injections rather than face the possibility of VAPP.8 Fifth, the cost of the inactivated and oral vaccines are now equivalent in the private sector, if ord red from the manufacturer directly (although the book price and the public purchase price of IPV are higher). Sixth, data show high acceptance (91%) of an IPV-starting schedule among parents bringing their children to public health vaccine clinics, including those serving inner-city disadvantaged areas, without decreases in immunization rates.9 Seventh, media attention on antivaccine efforts has grown, and VAPP is an issue due to OPV. Eighth, it is easier to administer and store 1 vaccine (IPV) than to explain the choices and stock 2 vaccines.
Kimmel and colleagues and others1-3 have also noted that dissemination of information on immunization protocols differs between the specialties and, other than the annual recommended schedule, pediatricians often hear the details first. Detailed recommendations on poliovirus vaccine appeared in 1997 in Pediatrics10 but American Family Physician printed the information in January 199911 (although editorials and brief reports appeared before the detailed article, which was delayed because of late-breaking research and policy changes).
Family physicians and pediatricians should differ for several reasons. For instance, specialty differences start in training, as most family practice residencies are based in community hospitals and emphasize outpatient medicine, while many pediatric residencies are based in tertiary care institutions with a greater emphasis on inpatient treatment. Following residency training the specialties differ again, with family physicians usually starting in practice, often in small towns, while many pediatricians pursue fellowships. The history of family medicine as a specialty that emphasizes outpatient medicine and the physician-patient relationship leads naturally to less emphasis on the judgment of a tertiary care specialist and more on shared decisions that reflect the patient’s values and economic situation. Immunization information sources also vary by specialty. Most pediatricians (74%) rate the Red Book12 the most important source for information, while family physicians cite a variety of sources: journals (44%), Red Book (34%), health department (11%), colleagues (5%), and others (6%).13
I believe that more timely in-depth dissemination of information on immunizations is needed for family physicians. Family physicians do differ from pediatricians, however, so the development of tools for delivering this information to family physicians is needed. There are many reasons why now is the time for a detailed and evidence-based text on immunizations across the life span by family physicians for family physicians:
- A cadre of experienced educators, clinicians, and researchers now exists within family medicine that can make sound evidence-based decisions (ie, the Group on Immunization Education in the Society of Teachers of Family Medicine and the Commission on Clinical Policies and Research in the AAFP).
- The AAFP took the lead in immunizations by being the first national organization to recommend routine influenza vaccination at age 50, a cost-effective recommendation that is supported by solid medical evidence.
- Family physicians who treat patients across the life span differ from physicians of other specialties and often partner with patients in decision making.
- Family physicians lack a single definitive text on immunizations and lack consensus on where to turn for this information.
- The immunization texts of other specialties lack family physician input and perspective.
- The immunization field is changing rapidly and will continue to do so.
To be successful, this text will need strong support from our professional societies, since distributing it widely will be expensive, and keeping it current will require considerable effort. Kimmel and coworkers have shown us that beliefs and information dissemination differ by specialty. I believe that it is time for family medicine to take the next step with an immunization textbook by our professional societies.
1. Kimmel SR, Puczynski S, McCoy RC, Puczynski MS. Practices of family physicians and pediatricians in administering poliovirus vaccine. J Fam Pract 1999;48:594-600.
2. Freed GL, Bordley WC, Clark SJ, et al. Universal hepatitis B immunization of infants: reactions of pediatricians and family physicians over time. Pediatrics 1994;93:747-51.
3. Zimmerman RK, Mieczkowski TA. How important is early childhood hepatitis B vaccination: a survey of primary care physicians. J Fam Pract 1998;47:370-4.
4. Centers for Disease Control. Certification of poliomyelitis eradication: the Americas, 1994. MMWR Morb Mortal Wkly Rep 1994;43:720.-
5. Centers for Disease Control and Prevention. Progress toward global eradication of poliomyelitis. MMWR Morb Mortal Wkly Rep 1997;46:579-84.
6. Centers for Disease Control and Prevention. Poliomyelitis prevention in the United States: introduction of a sequential vaccination schedule of inactivated poliovirus vaccine followed by oral poliovirus vaccine. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 1997;46(No. RR-3):1-25.
7. Centers for Disease Control and Prevention. Epidemiology & prevention of vaccine-preventable diseases: the pink book. 4th ed. Atlanta, Ga: Centers for Disease Control and Prevention; 1997.
8. Thoms ML, Bodnar PZ, O’Donovan JC, et al. Parental knowledge and choice regarding live and inactivated poliovirus vaccines. Arch Pediatr Adolesc Med 1997;151:809-12.
9. Desai S, Kolasa M, Bisgard K, et al. Is the new poliovirus immunization recommendation acceptable to parents? Abstracts of the 32nd National Immunization Conference, Atlanta, Ga, July 21-24, 1998.
10. American Academy of Pediatrics Committee on Infectious Diseases. Poliomyelitis prevention: recommendations for use of inactivated poliovirus vaccine and live oral poliovirus vaccine. Pediatrics 1997;99:300-5.
11. Zimmerman RK, Spann SJ. Poliomyelitis vaccine options. Am Fam Physician 1999;59:113-20.
12. Peter G, ed. Red book: report of the Committee on Infectious Diseases. 24th ed. Elk Grove Village, Ill: American Academy of Pediatrics; 1997;1-764.
13. Zimmerman RK, Schlesselman JJ, Baird AL, et al. A national survey to understand why physicians limit childhood immunizations. Arch Pediatr Adolesc Med 1997;151:657-64.
In this issue of the Journal, Kimmel and colleagues1 report the findings of a valuable study of Ohio family physicians’ and pediatricians’ beliefs about and reported practices of poliovirus immunization. The authors, led by Dr Kimmel, the chairman of the Group on Immunization Education of the Society of Teachers of Family Medicine, found that all physicians were aware of the 1997 poliovirus recommendations, but preferential use of oral poliovirus vaccine (OPV) was related to concerns about the cost of inactivate poliovirus vaccine (IPV) and increased number of injections, while use of the sequential schedule was a reaction to concerns about the risks of vaccine-associated paralytic poliomyelitis (VAPP) and liability.
Kimmel and coworkers found that 63% of family physicians administered OPV, while 67% of pediatricians administered the sequential schedule. Family physicians seem to be more concerned with cost than pediatricians and less concerned with litigation risk; these economic findings parallel findings by other researchers.2,3
One of the main reasons that the American Academy of Family Physicians (AAFP) encouraged parent-provider choice (instead of quickly recommending IPV) was the possibility that the number of injections in the sequential sequence could lead to outbreaks of other vaccine-preventable diseases if immunization rates dropped, especially in disadvantaged areas. The higher cost of IPV was another concern. Also, there was discussion of the importance of intestinal immunity, which is better when OPV is in the schedule. Thus in my opinion, the AAFP position was quite reasonable in 1997. However, in mid- and late 1998 when the price of IPV dropped, and when data became available that showed additional injections of IPV did not have an adverse impact on immunization rates even in disadvantaged communities, the AAFP position appropriately changed.
I believe that the poliovirus vaccine series should start with IPV, and that it makessense to move to the all IPV schedule for the year 2000. I offer several reasons. First, exposure to indigenous wild poliovirus in the United States has ceased. This is because of dramatic progress in poliomyelitis prevention; in 1994 the Americas were declared free of indigenous poliomyelitis, with the last case occurring in 1991 in Peru.4,5 There have been no cases of wild poliomyelitis contracted indigenously in the United States since 1979, and widespread circulation of indigenous wild polioviruses ceased in the 1960s.6 Second, OPV has a slight risk of VAPP, which can occur when the oral vaccine virus reverts to a more virulent form. Of the 125 cases of VAPP reported between 1980 and 1994, the affected individuals were: healthy vaccine recipients (49); healthy contacts of vaccine recipients (40); immunodeficient vaccine recipients (23); immunodeficient contacts of vaccine recipients (7); and community-acquired cases (6).7 VAPP was more common after the first dose of OPV in the all oral vaccine series; 40 of the 49 cases in healthy vaccine recipients occurred after the first dose. The overall risk of VAPP from the all oral vaccine series was 1 case per 2.4 million doses of OPV distributed (125 cases for the 303 million doses of OPV distributed in that time period).7 The risk for the first dose is 1 case per 750,000 first doses distributed. VAPP is paralytic; patients suffer, and their lives are often irreversibly altered. I believe that we can no longer justify the all OPV series in the United States, except in special limited circumstances, such as imminent overseas travel involving an infant. Third, IPV not live, cannot cause poliomyelitis, and thus is safe for immunocompromised patients. Fourth, the majority of parents (61%) prefer to have their child undergo more injections rather than face the possibility of VAPP.8 Fifth, the cost of the inactivated and oral vaccines are now equivalent in the private sector, if ord red from the manufacturer directly (although the book price and the public purchase price of IPV are higher). Sixth, data show high acceptance (91%) of an IPV-starting schedule among parents bringing their children to public health vaccine clinics, including those serving inner-city disadvantaged areas, without decreases in immunization rates.9 Seventh, media attention on antivaccine efforts has grown, and VAPP is an issue due to OPV. Eighth, it is easier to administer and store 1 vaccine (IPV) than to explain the choices and stock 2 vaccines.
Kimmel and colleagues and others1-3 have also noted that dissemination of information on immunization protocols differs between the specialties and, other than the annual recommended schedule, pediatricians often hear the details first. Detailed recommendations on poliovirus vaccine appeared in 1997 in Pediatrics10 but American Family Physician printed the information in January 199911 (although editorials and brief reports appeared before the detailed article, which was delayed because of late-breaking research and policy changes).
Family physicians and pediatricians should differ for several reasons. For instance, specialty differences start in training, as most family practice residencies are based in community hospitals and emphasize outpatient medicine, while many pediatric residencies are based in tertiary care institutions with a greater emphasis on inpatient treatment. Following residency training the specialties differ again, with family physicians usually starting in practice, often in small towns, while many pediatricians pursue fellowships. The history of family medicine as a specialty that emphasizes outpatient medicine and the physician-patient relationship leads naturally to less emphasis on the judgment of a tertiary care specialist and more on shared decisions that reflect the patient’s values and economic situation. Immunization information sources also vary by specialty. Most pediatricians (74%) rate the Red Book12 the most important source for information, while family physicians cite a variety of sources: journals (44%), Red Book (34%), health department (11%), colleagues (5%), and others (6%).13
I believe that more timely in-depth dissemination of information on immunizations is needed for family physicians. Family physicians do differ from pediatricians, however, so the development of tools for delivering this information to family physicians is needed. There are many reasons why now is the time for a detailed and evidence-based text on immunizations across the life span by family physicians for family physicians:
- A cadre of experienced educators, clinicians, and researchers now exists within family medicine that can make sound evidence-based decisions (ie, the Group on Immunization Education in the Society of Teachers of Family Medicine and the Commission on Clinical Policies and Research in the AAFP).
- The AAFP took the lead in immunizations by being the first national organization to recommend routine influenza vaccination at age 50, a cost-effective recommendation that is supported by solid medical evidence.
- Family physicians who treat patients across the life span differ from physicians of other specialties and often partner with patients in decision making.
- Family physicians lack a single definitive text on immunizations and lack consensus on where to turn for this information.
- The immunization texts of other specialties lack family physician input and perspective.
- The immunization field is changing rapidly and will continue to do so.
To be successful, this text will need strong support from our professional societies, since distributing it widely will be expensive, and keeping it current will require considerable effort. Kimmel and coworkers have shown us that beliefs and information dissemination differ by specialty. I believe that it is time for family medicine to take the next step with an immunization textbook by our professional societies.
In this issue of the Journal, Kimmel and colleagues1 report the findings of a valuable study of Ohio family physicians’ and pediatricians’ beliefs about and reported practices of poliovirus immunization. The authors, led by Dr Kimmel, the chairman of the Group on Immunization Education of the Society of Teachers of Family Medicine, found that all physicians were aware of the 1997 poliovirus recommendations, but preferential use of oral poliovirus vaccine (OPV) was related to concerns about the cost of inactivate poliovirus vaccine (IPV) and increased number of injections, while use of the sequential schedule was a reaction to concerns about the risks of vaccine-associated paralytic poliomyelitis (VAPP) and liability.
Kimmel and coworkers found that 63% of family physicians administered OPV, while 67% of pediatricians administered the sequential schedule. Family physicians seem to be more concerned with cost than pediatricians and less concerned with litigation risk; these economic findings parallel findings by other researchers.2,3
One of the main reasons that the American Academy of Family Physicians (AAFP) encouraged parent-provider choice (instead of quickly recommending IPV) was the possibility that the number of injections in the sequential sequence could lead to outbreaks of other vaccine-preventable diseases if immunization rates dropped, especially in disadvantaged areas. The higher cost of IPV was another concern. Also, there was discussion of the importance of intestinal immunity, which is better when OPV is in the schedule. Thus in my opinion, the AAFP position was quite reasonable in 1997. However, in mid- and late 1998 when the price of IPV dropped, and when data became available that showed additional injections of IPV did not have an adverse impact on immunization rates even in disadvantaged communities, the AAFP position appropriately changed.
I believe that the poliovirus vaccine series should start with IPV, and that it makessense to move to the all IPV schedule for the year 2000. I offer several reasons. First, exposure to indigenous wild poliovirus in the United States has ceased. This is because of dramatic progress in poliomyelitis prevention; in 1994 the Americas were declared free of indigenous poliomyelitis, with the last case occurring in 1991 in Peru.4,5 There have been no cases of wild poliomyelitis contracted indigenously in the United States since 1979, and widespread circulation of indigenous wild polioviruses ceased in the 1960s.6 Second, OPV has a slight risk of VAPP, which can occur when the oral vaccine virus reverts to a more virulent form. Of the 125 cases of VAPP reported between 1980 and 1994, the affected individuals were: healthy vaccine recipients (49); healthy contacts of vaccine recipients (40); immunodeficient vaccine recipients (23); immunodeficient contacts of vaccine recipients (7); and community-acquired cases (6).7 VAPP was more common after the first dose of OPV in the all oral vaccine series; 40 of the 49 cases in healthy vaccine recipients occurred after the first dose. The overall risk of VAPP from the all oral vaccine series was 1 case per 2.4 million doses of OPV distributed (125 cases for the 303 million doses of OPV distributed in that time period).7 The risk for the first dose is 1 case per 750,000 first doses distributed. VAPP is paralytic; patients suffer, and their lives are often irreversibly altered. I believe that we can no longer justify the all OPV series in the United States, except in special limited circumstances, such as imminent overseas travel involving an infant. Third, IPV not live, cannot cause poliomyelitis, and thus is safe for immunocompromised patients. Fourth, the majority of parents (61%) prefer to have their child undergo more injections rather than face the possibility of VAPP.8 Fifth, the cost of the inactivated and oral vaccines are now equivalent in the private sector, if ord red from the manufacturer directly (although the book price and the public purchase price of IPV are higher). Sixth, data show high acceptance (91%) of an IPV-starting schedule among parents bringing their children to public health vaccine clinics, including those serving inner-city disadvantaged areas, without decreases in immunization rates.9 Seventh, media attention on antivaccine efforts has grown, and VAPP is an issue due to OPV. Eighth, it is easier to administer and store 1 vaccine (IPV) than to explain the choices and stock 2 vaccines.
Kimmel and colleagues and others1-3 have also noted that dissemination of information on immunization protocols differs between the specialties and, other than the annual recommended schedule, pediatricians often hear the details first. Detailed recommendations on poliovirus vaccine appeared in 1997 in Pediatrics10 but American Family Physician printed the information in January 199911 (although editorials and brief reports appeared before the detailed article, which was delayed because of late-breaking research and policy changes).
Family physicians and pediatricians should differ for several reasons. For instance, specialty differences start in training, as most family practice residencies are based in community hospitals and emphasize outpatient medicine, while many pediatric residencies are based in tertiary care institutions with a greater emphasis on inpatient treatment. Following residency training the specialties differ again, with family physicians usually starting in practice, often in small towns, while many pediatricians pursue fellowships. The history of family medicine as a specialty that emphasizes outpatient medicine and the physician-patient relationship leads naturally to less emphasis on the judgment of a tertiary care specialist and more on shared decisions that reflect the patient’s values and economic situation. Immunization information sources also vary by specialty. Most pediatricians (74%) rate the Red Book12 the most important source for information, while family physicians cite a variety of sources: journals (44%), Red Book (34%), health department (11%), colleagues (5%), and others (6%).13
I believe that more timely in-depth dissemination of information on immunizations is needed for family physicians. Family physicians do differ from pediatricians, however, so the development of tools for delivering this information to family physicians is needed. There are many reasons why now is the time for a detailed and evidence-based text on immunizations across the life span by family physicians for family physicians:
- A cadre of experienced educators, clinicians, and researchers now exists within family medicine that can make sound evidence-based decisions (ie, the Group on Immunization Education in the Society of Teachers of Family Medicine and the Commission on Clinical Policies and Research in the AAFP).
- The AAFP took the lead in immunizations by being the first national organization to recommend routine influenza vaccination at age 50, a cost-effective recommendation that is supported by solid medical evidence.
- Family physicians who treat patients across the life span differ from physicians of other specialties and often partner with patients in decision making.
- Family physicians lack a single definitive text on immunizations and lack consensus on where to turn for this information.
- The immunization texts of other specialties lack family physician input and perspective.
- The immunization field is changing rapidly and will continue to do so.
To be successful, this text will need strong support from our professional societies, since distributing it widely will be expensive, and keeping it current will require considerable effort. Kimmel and coworkers have shown us that beliefs and information dissemination differ by specialty. I believe that it is time for family medicine to take the next step with an immunization textbook by our professional societies.
1. Kimmel SR, Puczynski S, McCoy RC, Puczynski MS. Practices of family physicians and pediatricians in administering poliovirus vaccine. J Fam Pract 1999;48:594-600.
2. Freed GL, Bordley WC, Clark SJ, et al. Universal hepatitis B immunization of infants: reactions of pediatricians and family physicians over time. Pediatrics 1994;93:747-51.
3. Zimmerman RK, Mieczkowski TA. How important is early childhood hepatitis B vaccination: a survey of primary care physicians. J Fam Pract 1998;47:370-4.
4. Centers for Disease Control. Certification of poliomyelitis eradication: the Americas, 1994. MMWR Morb Mortal Wkly Rep 1994;43:720.-
5. Centers for Disease Control and Prevention. Progress toward global eradication of poliomyelitis. MMWR Morb Mortal Wkly Rep 1997;46:579-84.
6. Centers for Disease Control and Prevention. Poliomyelitis prevention in the United States: introduction of a sequential vaccination schedule of inactivated poliovirus vaccine followed by oral poliovirus vaccine. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 1997;46(No. RR-3):1-25.
7. Centers for Disease Control and Prevention. Epidemiology & prevention of vaccine-preventable diseases: the pink book. 4th ed. Atlanta, Ga: Centers for Disease Control and Prevention; 1997.
8. Thoms ML, Bodnar PZ, O’Donovan JC, et al. Parental knowledge and choice regarding live and inactivated poliovirus vaccines. Arch Pediatr Adolesc Med 1997;151:809-12.
9. Desai S, Kolasa M, Bisgard K, et al. Is the new poliovirus immunization recommendation acceptable to parents? Abstracts of the 32nd National Immunization Conference, Atlanta, Ga, July 21-24, 1998.
10. American Academy of Pediatrics Committee on Infectious Diseases. Poliomyelitis prevention: recommendations for use of inactivated poliovirus vaccine and live oral poliovirus vaccine. Pediatrics 1997;99:300-5.
11. Zimmerman RK, Spann SJ. Poliomyelitis vaccine options. Am Fam Physician 1999;59:113-20.
12. Peter G, ed. Red book: report of the Committee on Infectious Diseases. 24th ed. Elk Grove Village, Ill: American Academy of Pediatrics; 1997;1-764.
13. Zimmerman RK, Schlesselman JJ, Baird AL, et al. A national survey to understand why physicians limit childhood immunizations. Arch Pediatr Adolesc Med 1997;151:657-64.
1. Kimmel SR, Puczynski S, McCoy RC, Puczynski MS. Practices of family physicians and pediatricians in administering poliovirus vaccine. J Fam Pract 1999;48:594-600.
2. Freed GL, Bordley WC, Clark SJ, et al. Universal hepatitis B immunization of infants: reactions of pediatricians and family physicians over time. Pediatrics 1994;93:747-51.
3. Zimmerman RK, Mieczkowski TA. How important is early childhood hepatitis B vaccination: a survey of primary care physicians. J Fam Pract 1998;47:370-4.
4. Centers for Disease Control. Certification of poliomyelitis eradication: the Americas, 1994. MMWR Morb Mortal Wkly Rep 1994;43:720.-
5. Centers for Disease Control and Prevention. Progress toward global eradication of poliomyelitis. MMWR Morb Mortal Wkly Rep 1997;46:579-84.
6. Centers for Disease Control and Prevention. Poliomyelitis prevention in the United States: introduction of a sequential vaccination schedule of inactivated poliovirus vaccine followed by oral poliovirus vaccine. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 1997;46(No. RR-3):1-25.
7. Centers for Disease Control and Prevention. Epidemiology & prevention of vaccine-preventable diseases: the pink book. 4th ed. Atlanta, Ga: Centers for Disease Control and Prevention; 1997.
8. Thoms ML, Bodnar PZ, O’Donovan JC, et al. Parental knowledge and choice regarding live and inactivated poliovirus vaccines. Arch Pediatr Adolesc Med 1997;151:809-12.
9. Desai S, Kolasa M, Bisgard K, et al. Is the new poliovirus immunization recommendation acceptable to parents? Abstracts of the 32nd National Immunization Conference, Atlanta, Ga, July 21-24, 1998.
10. American Academy of Pediatrics Committee on Infectious Diseases. Poliomyelitis prevention: recommendations for use of inactivated poliovirus vaccine and live oral poliovirus vaccine. Pediatrics 1997;99:300-5.
11. Zimmerman RK, Spann SJ. Poliomyelitis vaccine options. Am Fam Physician 1999;59:113-20.
12. Peter G, ed. Red book: report of the Committee on Infectious Diseases. 24th ed. Elk Grove Village, Ill: American Academy of Pediatrics; 1997;1-764.
13. Zimmerman RK, Schlesselman JJ, Baird AL, et al. A national survey to understand why physicians limit childhood immunizations. Arch Pediatr Adolesc Med 1997;151:657-64.